Arrowhead Pharmaceuticals Stock Target Price and Analyst Consensus

ARWR
 Stock
  

USD 33.93  1.91  5.97%   

The current analyst and expert consensus on Arrowhead Pharmaceuticals is Buy, with 6 strong buy opinions. The current projected Arrowhead Pharmaceuticals target price consensus is 89.5 with 8 analyst opinions. The most common way Arrowhead Pharmaceuticals analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Arrowhead Pharmaceuticals executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Arrowhead Pharmaceuticals. We strongly encourage you to use your own analysis of Arrowhead Pharmaceuticals to validate this buy or sell advice. Arrowhead Pharmaceuticals buy-or-sell recommendation module provides average expert sentiment on the projected Arrowhead Pharmaceuticals target price to derive its highest and lowest estimates based on projected price volatility of 19.949. Please continue to Macroaxis Advice on Arrowhead Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
  
As of 12/05/2022, Gross Profit is likely to grow to about 171.6 M, while Profit Margin is likely to drop (113.42) . Arrowhead Pharmaceuticals Debt Current is relatively stable at the moment as compared to the past year. Arrowhead Pharmaceuticals reported last year Debt Current of 2.59 Million. As of 12/05/2022, Debt Non Current is likely to grow to about 28.9 M, while Accumulated Other Comprehensive Income is likely to drop (67 K).

Arrowhead Pharmaceuticals Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Arrowhead target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts performance other than comparing it to the past results via a very sophisticated attribution analysis. Arrowhead target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
Number of Opinions7
Lowered Outlook0
Raized Outlook0
Buy
Most Arrowhead analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Arrowhead stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Arrowhead Pharmaceuticals, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Arrowhead Pharmaceuticals Target Price Projection

Arrowhead Pharmaceuticals' current and average target prices are 33.93 and 89.50, respectively. The current price of Arrowhead Pharmaceuticals is the price at which Arrowhead Pharmaceuticals is currently trading. On the other hand, Arrowhead Pharmaceuticals' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Arrowhead Pharmaceuticals Market Quote on 5th of December 2022

Low Price31.38Odds
High Price34.18Odds

33.93

Target Price

Analyst Consensus On Arrowhead Pharmaceuticals Target Price

Low Estimate45.0Odds
High Estimate106.0Odds
Number of Analysts8
Standard Deviation19.949

89.5

Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Arrowhead Pharmaceuticals and the information provided on this page.

Arrowhead Pharmaceuticals Analyst Ratings

Arrowhead Pharmaceuticals' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Arrowhead Pharmaceuticals stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Arrowhead Pharmaceuticals' financials, market performance, and future outlook by experienced professionals. Arrowhead Pharmaceuticals' historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

About Arrowhead Pharmaceuticals Target Price Projections

Arrowhead Pharmaceuticals's target price is an analyst's projection of its future price. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Arrowhead Pharmaceuticals and even bonds. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. When setting a price target estimate, an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. Generally, the target price of Arrowhead depends on its intrinsic valuation, beta (i.e., risk over market), and overall volatility. Most analysts publish their price targets in research reports on specific companies, along with their buy, hold, or sell recommendations. Stock price targets are often quoted in the financial news media. Macroaxis uses multiple feeds to provide overall target price projection for Arrowhead Pharmaceuticals including analysis of its current option contracts.
Arrowhead Pharmaceuticals' latest option contracts expiring on 2022-12-16 are carrying combined implied volatility of 84.16 with a put-to-call open interest ratio of 0.23 over 28 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2022-12-16. The current put volume is at 169, with calls trading at the volume of 251. This yields a 0.67 put-to-call volume ratio. The Arrowhead Pharmaceuticals option chain provides detailed quote and price information for the current Arrowhead Pharmaceuticals option contracts. It shows all of Arrowhead Pharmaceuticals' listed puts, calls, expiration dates, strike prices, and other pricing information.

Open Interest Against 2022-12-16 Option Contracts

Arrowhead Pharmaceuticals option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Arrowhead Pharmaceuticals' lending market. For example, when Arrowhead Pharmaceuticals' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Arrowhead Pharmaceuticals, he or she must hedge the risk by shorting Arrowhead Pharmaceuticals stock over its option's life.
The chart above shows Arrowhead Pharmaceuticals' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Arrowhead Pharmaceuticals' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Arrowhead Pharmaceuticals' option, there is no secondary market available for investors to trade.

Arrowhead Pharmaceuticals Maximum Pain Price across 2022-12-16 Option Contracts

Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Arrowhead Pharmaceuticals close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Arrowhead Pharmaceuticals' stock options are financial instruments that give investors the right to buy or sell shares of Arrowhead Pharmaceuticals common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Arrowhead stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Arrowhead Pharmaceuticals' stock price goes up or down, the stock options follow.
Please continue to Macroaxis Advice on Arrowhead Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.

Arrowhead Pharmaceuticals In The Money Call Balance

When Arrowhead Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Arrowhead Pharmaceuticals stock is said to be in the money. When it comes to buying Arrowhead Pharmaceuticals' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Arrowhead Pharmaceuticals are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Arrowhead Current Options Market Mood

Arrowhead Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Arrowhead Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Arrowhead Pharmaceuticals' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Arrowhead Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Arrowhead Pharmaceuticals' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Additional Arrowhead Pharmaceuticals Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Arrowhead Pharmaceuticals is a key component of Arrowhead Pharmaceuticals valuation and have some predictive power on the future returns of a Arrowhead Pharmaceuticals.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Arrowhead Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Arrowhead Pharmaceuticals in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
29.5333.8138.09
Details
Intrinsic
Valuation
LowReal ValueHigh
30.5446.9551.23
Details
Earnings
Estimates (8)
LowProjected EPSHigh
-3.51-0.693.12
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Arrowhead Pharmaceuticals. Your research has to be compared to or analyzed against Arrowhead Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Arrowhead Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Arrowhead Pharmaceuticals.

Additional Arrowhead Pharmaceuticals Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Arrowhead Pharmaceuticals is a key component of Arrowhead Pharmaceuticals valuation and have some predictive power on the future returns of a Arrowhead Pharmaceuticals.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Arrowhead Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Arrowhead Pharmaceuticals in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
29.5333.8138.09
Details
Intrinsic
Valuation
LowReal ValueHigh
30.5446.9551.23
Details
Earnings
Estimates (8)
LowProjected EPSHigh
-3.51-0.693.12
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Arrowhead Pharmaceuticals. Your research has to be compared to or analyzed against Arrowhead Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Arrowhead Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Arrowhead Pharmaceuticals.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Technology
Invested over 20 shares
Impulse
Invested over 200 shares
Corona Opportunity
Invested few shares
Diversified Assets
Invested over 60 shares
Driverless Cars
Invested few shares
Macroaxis Index
Invested one share
Disruptive Technologies
Invested one share
Power Stocks
Invested one share
Please continue to Macroaxis Advice on Arrowhead Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try Focused Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Complementary Tools for analysis

When running Arrowhead Pharmaceuticals price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
The data published in Arrowhead Pharmaceuticals' official financial statements usually reflect Arrowhead Pharmaceuticals' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Arrowhead Pharmaceuticals. For example, before you start analyzing numbers published by Arrowhead accountants, it's critical to develop an understanding of what Arrowhead Pharmaceuticals' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Arrowhead Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Arrowhead Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Arrowhead Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Arrowhead Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Arrowhead Pharmaceuticals' management to manipulate its earnings.